Eisenmenger's syndrome and pregnancy

Management of labor in Eisenmenger syndrome with inhaled nitric oxide

Administration of nitric oxide by means of inhalation during the labor of a woman with Eisenmenger's syndrome caused by an atrial septal defect resulted in improved oxygenation and initial pulmonary arterial pressure. She gave birth to a live infant at 34 weeks' gestation but died of worsening pulmonary hypertension and heart failure 21 days post partum.

Cardiac disease in pregnancy

Pregnancy produces many hemodynamic alterations of the cardiovascular system. Consideration of these alterations must be given in the management of pregnant patients with cardiac disease. This article reviews the cardiovascular hemodynamic alterations of pregnancy, and the management of pregnant patients with specific cardiac lesions.

Eisenmenger's syndrome and pregnancy

Two cases of successfully managed Eisenmenger's syndrome during pregnancy are reported. A women suffering from Eisenmenger's syndrome who becomes pregnant should be advised to have her pregnancy terminated. On the basis of the available literature and our own experiences we suggest the following plan, if a woman, despite medical advice, chooses to continue her pregnancy: admission to hospital at approximately 25 weeks of gestation; bed rest during the remaining period of pregnancy; oxygen face-mask during episodes of dyspnoea; determination of serial blood gases to detect changes in the shunt flow. At the onset of labour, arterial and epidural catheters should be inserted, a fall in blood pressure should immediately be counteracted by the administration of norepinephrine and loss of blood by transfusion. The patient should remain in hospital for 7-14 days after delivery.

Primary pulmonary hypertension and pregnancy

Despite the preponderance of primary pulmonary hypertension (PPH) in young female subjects, documented cases of PPH in association with pregnancy are uncommon. During a 12-month period, 73 female patients with PPH were evaluated as potential recipients of a heart-lung transplant; and in six (8 percent), PPH appeared to be related to pregnancy. Histologic confirmation of the diagnosis was available in four patients, and other causes of pulmonary hypertension were excluded as far as possible in the remaining two patients.

Eisenmenger's syndrome and the pregnant patient

The presence of Eisenmenger's syndrome places the pregnant patient at high risk for maternal and neonatal mortality. Since patients with Eisenmenger's syndrome generally survive until the fourth decade, some patients with this disease process will become pregnant. A discussion of cardiovascular changes that occur during pregnancy is presented with a description of the manifestations of Eisenmenger's syndrome. The literature on Eisenmenger's syndrome in pregnancy is reviewed and a therapeutic approach to the management of the pregnant patient with this disease is presented.

Shunt flow and pulmonary hemodynamics during labor and delivery in the Eisenmenger syndrome

The Eisenmenger syndrome carries a high mortality rate in a women during delivery and the immediate postpartum period. It has been suggested that marked changes in shunt flow and pulmonary hemodynamics may be responsible. These functions were studied under various physiologic and pharmacologic conditions during labor and delivery in a patient with the Eisenmenger syndrome. Uterine contractions were associated with a decrease in the ratio of pulmonary to systemic blood flow (Qp/Qs) from 1.58 to 1.05. The Qp/Qs ratio also decreased (to 0.83) when forceps were applied during uterine contractions. Epidural anesthesia, oxytocin and the supine position did not adversely affect pulmonary hemodynamics or shunt flow. On the basis of these results, if pregnancy cannot be terminated in a patient with the Eisenmenger syndrome, it is recommended that the patient be given high concentration of oxygen and epidural anesthesia and that serial arterial blood gas determinations be performed to detect changes in shunt flow.

Heart disease and pregnancy at the Royal Women's Hospital

The management of 542 women with heart disease and pregnancy during the years 1950 to 1975 is described. All were classified according to their cardiac function at the onset of pregnancy. The incidence of heart failure is recorded and the factors which determined this are discussed. Mitral valvotomy was performed during pregnancy in 13 women, however 31 had had mitral valvotomy before pregnancy. There were 10 maternal deaths, eight of these occurring during the puerperium.

Eisenmenger's syndrome in pregnancy: does heparin prophylaxis improve the maternal mortality rate?

Seven consecutive patients with Eisenmenber's syndrome, cared for by the obstetric team in conjunction with the cardiology service, were reviewed to assess the possible role of prophylactic heparin therapy and intensive care on the outcome of these patients. In each patient, the diagnosis of Eisenmenger's syndrome was established by the demonstration of equal pulmonary arterial and aortic pressures with a predominantly right-to-left shunt at cardiac catheterization. Five of the seven patients died as follows: Three patients died between the fifth and eighth post-partum days, one patient died during the twenty-sixth week of pregnancy, and one patient died on the fifth postoperative day following tubal ligation. All of these five patients received prophylactic heparin therapy. In three patients, heparin therapy was complicated by excessive bleeding during the postoperative or postpartum period. Autopsy examination in two patients revealed no evidence of thrombosis in the main pulmonary arteries and no pulmonary infarction, contrary to the antemortem clinical suspicion. The two survivors did not receive prophylactic heparin. They comprised one patient who had normal delivery and one patient who underwent tubal ligation and induction of abortion. We conclude that the prohibitive mortality rate of Eisenmenger's syndrome during pregnancy, puerpurium, or surgical procedures probably cannot be modified with prophylactic heparin therapy. Anticoagulant treatment does not prevent deterioration of patients and probably compounds the problem by causing significant bleeding.